More Than 180 New Diabetes Drugs in Development


By: Diabetes Health Staff

A total of 182 new drugs to treat diabetes or diabetes-related conditions are currently in clinical trials or undergoing review by the U.S. Food and Drug Administration, according to a report just published by the Pharmaceutical Research and Manufacturers of America (PhRMA).

Of that number, 30 drugs are aimed at type 1 diabetes, 100 are aimed at type 2, and 52 are aimed at diabetes-related conditions, such as diabetic neuropathy.

According to PhRMA, among the approaches the new drugs will take include:

• A treatment designed to stimulate and enhance the regeneration of insulin-producing cells for type 1 diabetes

• A medicine that improves glucose-dependent insulin secretion for type 2 diabetes

• A medicine designed to inhibit an enzyme linked to diabetic neuropathy

The PhRMA report detailing to new drug developments also states that there are 200 diabetes drug clinical trials either active or scheduled in the United States. (Sixty are active; 140 are now recruiting or planning to recruit diabetes patient participants.)

A PDF of the full PhRMA report, “Medicines in Development: Diabetes,” is available at

The PDF includes a complete chart of the drugs under development, including their names and types, who makes them, what they target (type, 1, type 2, etc.), and their current stage of development.

The chart also provides links to the manufacturers’ websites.



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.